Neoadjuvant Darovasertib in Primary Uveal Melanoma

IsraelRecruitingPHASE3

Conditions

Uveal Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Mayo Clinic Scottsdale - PPDS, Scottsdale, Arizona, United States

    Contact: Study coordinator (Odette Houghton, MD Principal Investigator)
  • UCSD Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Gregory Daniels, MD Principal Investigator)
  • Jules Stein Eye Institute, Los Angeles, California, United States

    Contact: Study coordinator (Tara McCannel, MD Principal Investigator)
  • USC Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Gino In, MD, Principal Investigator)
  • University of California Irvine Medical Center, Orange, California, United States

    Contact: Study coordinator (Poorva Vaidya, MD Principal Investigator)
  • Stanford Comprehensive Cancer Center, Palo Alto, California, United States

    Contact: Study coordinator (Pauline Funchain, MD Principal Investigator)
  • Kaiser Permanente-Riverside Medical Center, Riverside, California, United States

    Contact: Study coordinator (Helen Moon, MD Principal Investigator)
  • UCSF Wayne and Gladys Valley Center for Vision, San Francisco, California, United States

    Contact: Study coordinator (Armin Afshar, MD, Principal Investigator)
  • University of Colorado Hospital, Aurora, Colorado, United States

    Contact: Study coordinator (Sapna Patel, MD Principal Investigator)
  • The Melanoma and Skin Cancer Institute, Englewood, Colorado, United States

    Contact: Study coordinator (Ryan Weight, MD Principal Investigator)
  • Mayo Clinic Jacksonville, Jacksonville, Florida, United States

    Contact: Study coordinator (Bently Doonan, MD Principal Investigator)
  • USF Health Eye Institute, Tampa, Florida, United States

    Contact: Study coordinator (Jorge Agi, MD Principal Investigator)
  • Moffit Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Nikhil Khushalani, MD, Principal Investigator)
  • Wilmer Eye Institute, Baltimore, Maryland, United States

    Contact: Study coordinator (James Handa, MD Principal Investigator)
  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Kamaneh Montazeri, MD Principal Investigator)
  • W Kellogg Eye Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Hakan Demirci, MD Principal Investigator)
  • The Cancer and Hematology Centers of West Michigan (CHCWM), Grand Rapids, Michigan, United States

    Contact: Study coordinator (Sreenivasa Chandana, MD Principal Investigator)
  • Mayo Clinic - PPDS, Rochester, Minnesota, United States

    Contact: Study coordinator (Lauren Dalvin, MD Principal Investigator)
  • TIERING Percentiles, Omaha, Nebraska, United States

    Contact: Study coordinator (Pukhraj Rishi, MD Principal Investigator)
  • Herbert Irving Comprehensive Cancer Center, New York, New York, United States

    Contact: Study coordinator (Benjamin Izar, MD Principal Investigator)
  • Memorial Sloan Kettering Cancer Center - 1275 York Ave, New York, New York, United States

    Contact: Study coordinator (Jasmine Francis, MD Principal Investigator)
  • Northwell Health Cancer Institute, New York, New York, United States

    Contact: Study coordinator (Shaheer Khan, MD Principal Investigator)
  • Cole Eye Institute-9500 Euclid Ave, Cleveland, Ohio, United States

    Contact: Study coordinator (Lucy Kennedy, MD Principal Investigator)
  • Ohio State Eye and Ear Institute, Columbus, Ohio, United States

    Contact: Study coordinator (Colleen Cebulla, MD Principal Investigator)
  • Retina Consultants of Oklahoma, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Brian Firestone, MD, Principal Investigator)
  • Jefferson Health Honickman Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Marlana Orloff, MD Principal Investigator)
  • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Yana Najjar, MD Principal Investigator)
  • SCRI Oncology Partners, Nashville, Tennessee, United States

    Contact: Study coordinator (Meredith McKean, MD Principal Investigator)
  • Vanderbilt Eye Institute, Nashville, Tennessee, United States

    Contact: Study coordinator (Paul Sternberg, MD, Principal Investigator)
  • Austin Retina Associates - Central, Austin, Texas, United States

    Contact: Study coordinator (Shelley Ghafoori, MD Principal Investigator)
  • Texas Retina Associates - Dallas, Dallas, Texas, United States

    Contact: Study coordinator (Timothy Fuller, MD Principal Investigator)
  • University of Texas Southwestern Medical Center-5323 Harry Hines Blvd, Dallas, Texas, United States

    Contact: Study coordinator (Sanjay Chandrasekaran, MD Principal Investigator)
  • Retina Consultants of Texas - (Houston), Houston, Texas, United States

    Contact: Study coordinator (Amy Schefler, MD Principal Investigator)
  • Augusta Health, Center for Cancer and Blood Disorders, Fishersville, Virginia, United States

    Contact: Study coordinator (Kelvin Rayborn, MD Principal Investigator)
  • University of Wisconsin Health, Madison, Wisconsin, United States

    Contact: Study coordinator (Michael Altaweel, MD Principal Investigator)
  • Gallipoli Medical Research Foundation, Greenslopes, Queensland, Australia

    Contact: Study coordinator (Victoria Atkinson, MD, Principal Investigator)
  • The Queen Elizabeth Hospital, Woodville South, South Australia, Australia

    Contact: Study coordinator (Rachel Roberts-Thomson, MD Principal Investigator)
  • The Alfred Hospital, Melbourne, Victoria, Australia

    Contact: Study coordinator (Mark Shackleton, MD Principal Investigator)
  • The Crown Princess Mary Cancer Centre (Westmead Hospital), NSW 214, Westmead, Australia

    Contact: Study coordinator (Matteo Carlino, MD, Principal Investigator)
  • LKH-Universitätsklinikum Graz, Graz, Austria

    Contact: Study coordinator (Thomas Georgi, MD Principal Investigator)
  • Universitätsklinikum Innsbruck, Innsbruck, Austria

    Contact: Study coordinator (Matus Rehak, MD Principal Investigator)
  • Universitätsklinikum AKH Wien, Vienna, Austria

    Contact: Study coordinator (Roman Dunavölgyi, MD Principal Investigator)
  • Cliniques Universitaires Saint-Luc - PPDS, Brussels, Belgium

    Contact: Study coordinator (Jean-Francois Baurain, MD Principal Investigator)
  • UZ Leuven - PPDS, Leuven, Belgium

    Contact: Study coordinator (Joachim Van Calster, MD Principal Investigator)
  • Cross Cancer Institute, Edmonton, Alberta, Canada

    Contact: Study coordinator (John Walker, MD, Principal Investigator)
  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

    Contact: Study coordinator (Marcus Butler, MD Principal Investigator)
  • Ustredni vojenska nemocnice - Vojenska fakultni nemocnice Praha, Prague, Prague, Czechia

    Contact: Study coordinator (Zuzana Hradcova, MD Principal Investigator)
  • Rigshospitalet, Copenhagen O, Capital, Denmark

    Contact: Study coordinator (Jens Kiilgaard, MD Principal Investigator)
  • Aarhus Universitetshospital, Aarhus, Central Jutland, Denmark

    Contact: Study coordinator (Peter Skov Jensen, MD Principal Investigator)
  • East Tallinn Central Hospital-Pärnu road 104, Tallinn, Harju, Estonia

    Contact: Study coordinator (Elen Vettus, MD Principal Investigator)
  • CHU de Nice-Hôpital Pasteur, Nice, Alpes-Maritimes, France

    Contact: Study coordinator (Sacha Nahon-Estève, MD Principal Investigator)
  • Centre Retine Gallien - Bordeaux, Bordeaux, Gironde, France

    Contact: Study coordinator (Laurence Rosier, MD Principal Investigator)
  • CHU de Rennes - Hôpital Pontchaillou, Rennes, Ille-et-Vilaine, France

    Contact: Study coordinator (Frederic Mouriaux, MD Principal Investigator)
  • Institut Curie - Hôpital de Paris, Paris, Paris, France

    Contact: Study coordinator (Alexandre Matet, MD Principal Investigator)
  • Centre Hospitalier National D'ophtalmologie Des Quinze Vingts, Paris, France

    Contact: Study coordinator (Sarah Tick, MD Principal Investigator)
  • Universitätsklinikum Tübingen, Tübingen, Baden-Wurttemberg, Germany

    Contact: Study coordinator (Daniela Süsskind, MD Principal Investigator)
  • Universitätsklinikum Ulm, Ulm, Baden-Wurttemberg, Germany

    Contact: Study coordinator (Armin Wolf, MD Principal Investigator)
  • Hautklinik Erlangen, Erlangen, Bavaria, Germany

    Contact: Study coordinator (Carola Berking, MD Principal Investigator)
  • Universitätsklinikum Essen, Essen, North Rhine-Westphalia, Germany

    Contact: Study coordinator (Halime Kalkavan, MD Principal Investigator)
  • Städtisches Klinikum Dessau, Dessau, Saxony-Anhalt, Germany

    Contact: Study coordinator (Lothar Krause, MD Principal Investigator)
  • Charité - Universitätsmedizin Berlin, Berlin, Germany

    Contact: Study coordinator (Antonia Joussen, MD Principal Investigator)
  • Universitätsklinikum Bonn, Bonn, Germany

    Contact: Study coordinator (Thomas Ach, MD Principal Investigator)
  • Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck, Germany

    Contact: Study coordinator (Svenja Sonntag, Principal Investigator, MD)
  • Universitätsklinikum Giessen und Marburg - Marburg (UKGM), Marburg, Germany

    Contact: Study coordinator (Walter Sekundo, MD Principal Investigator)
  • Universitätsklinikum Würzburg, Würzburg, Germany

    Contact: Study coordinator (Andreas Berlin, MD Principal Investigator)
  • PAGNI-University General Hospital of Heraklion, Heraklion, Irakleio, Greece

    Contact: Study coordinator (Efstathios Detorakis, MD Principal Investigator)
  • University General Hospital of Larissa, Larissa, Larissa, Greece

    Contact: Study coordinator (Sofia Androudi, MD Principal Investigator)
  • AHEPA University General Hospital of Thessaloniki, Thessaloniki, Thessaloníki, Greece

    Contact: Study coordinator (Konstantinos Boboridis, MD Principal Investigator)
  • The Chaim Sheba Medical Center - PPDS, Ramat Gan, Central District, Israel

    Contact: Study coordinator (Vicktoria Vishnevskia-Dai, MD Principal Investigator)
  • Hadassah Medical Center - PPDS, Jerusalem, Jerusalem, Israel

    Contact: Study coordinator (Shahar Frenkel, MD Principal Investigator)
  • Istituto Nazionale Tumori IRCCS Fondazione Giovanni Pascale, Naples, Campania, Italy

    Contact: Study coordinator (Paolo Ascierto, MD Principal Investigator)
  • ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco, Milan, Milan, Italy

    Contact: Study coordinator (Marco Pellegrini, MD Principal Investigator)
  • Azienda Ospedaliera di Perugia - Ospedale Santa Maria della Misericordia, Perugia, Perugia, Italy

    Contact: Study coordinator (Mario Mandalà, MD Principal Investigator)
  • Azienda Ospedaliera Universitaria Careggi, Florence, Tuscany, Italy

    Contact: Study coordinator (Cinzia Mazzini, MD Principal Investigator)
  • Azienda Ospedaliera di Perugia - Ospedale Santa Maria della Misericordia, Pisa, Italy

    Contact: Study coordinator (Federica Genovesi Ebert, MD Principal Investigator)
  • Fondazione Policlinico Universitario A Gemelli - Rome - PPDS, Rome, Italy

    Contact: Study coordinator (Ernesto Rossi, MD Principal Investigator)
  • Erasmus MC, Rotterdam, South Holland, Netherlands

    Contact: Study coordinator (Emine Kiliç-Ciğirci, MD Principal Investigator)
  • Auckland Eye, Auckland, Auckland, New Zealand

    Contact: Study coordinator (Riyaz Bhikoo, MD Principal Investigator)
  • Uniwersytecki Szpital Kliniczny w Poznaniu- Dluga 1/2, Poznan, Greater Poland Voivodeship, Poland

    Contact: Study coordinator (Iwona Rospond-Kubiak, MD Principal Investigator)
  • WIM-PIB, Centralny Szpital Kliniczny MON, Warsaw, Masovian Voivodeship, Poland

    Contact: Study coordinator (Izabela Nowak-Gospodarowicz, MD Principal Investigator)
  • Uniwersyteckie Centrum Kliniczne w Gdansku - Debinki 7, Gdansk, Pomeranian Voivodeship, Poland

    Contact: Study coordinator (Kamil Drucis, MD Principal Investigator)
  • Fakultna nemocnica s poliklinikou F. D. Roosevelta, Banská Bystrica, Slovakia

    Contact: Study coordinator (Ladislav Janco, MD Principal Investigator)
  • Institute of Oncology Ljubljana, Ljubljana, Ljubljana, Slovenia

    Contact: Study coordinator (Janja Ocvirk, MD Principal Investiagtor)
  • Hospital Clinico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain

    Contact: Study coordinator (Maria José Blanco Teijeiro, MD Principal Investigator)
  • Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain

    Contact: Study coordinator (Jose Maria Caminal Mitjana, MD Principal Investigator)
  • Clinica Universidad Navarra, Pamplona, Navarre, Spain

    Contact: Study coordinator (Alfredo Garcia Layana, MD Principal Investigator)
  • Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Valencia, Spain

    Contact: Study coordinator (Rafael Martínez-Costa Pérez, MD Principal Investigator)
  • Hospital Clinico Universitario de Valladolid, Valladolid, Valladolid, Spain

    Contact: Study coordinator (Ciro Garcia-Alvarez, MD Principal Investigator)
  • Hospital Universitario Virgen Macarena, Seville, Spain

    Contact: Study coordinator (Francisco Espejo-Arjona, MD Principal Investigator)
  • Universitätsspital Basel, Basel, Switzerland

    Contact: Study coordinator (Andreas Schmitt, MD Principal Investigator)
  • Universitätsspital Zürich, Zurich, Switzerland

    Contact: Study coordinator (Egle Ramelyte, MD Principal Investigator)
  • Clatterbridge Cancer Centre - Liverpool - NWCRN - PPDS, Metropolitan Borough of Wirral, Merseyside, United Kingdom

    Contact: Study coordinator (Joseph Sacco, MD Principal Investigator)
  • University College Hospital, London, United Kingdom

    Contact: Study coordinator (Heather Shaw, MD Principal Investigator)
  • Weston Park Cancer Centre - PPDS, Sheffield, United Kingdom

    Contact: Study coordinator (Krishnakumar Garadi, MD Principal Investigator)